Does lyrica related weight gain differ with specific diets?

Weight Gain and Lyrica: Do Specific Diets Make a Difference?

While pregabalin (Lyrica) is primarily used to treat epilepsy, anxiety disorders, fibromyalgia, and nerve pain, researchers have found that many patients experience weight gain as a common side effect [1]. However, the extent to which different diets contribute to this phenomenon is still not fully understood.

How Much Weight Gain Can We Expect?

According to a meta-analysis of clinical trials, patients treated with pregabalin gained an average of 4.5 pounds (2 kg) more than those on a placebo during the first year of treatment [2]. However, this weight gain can vary significantly depending on individual factors, including diet and exercise habits.

Do Specific Diets Make a Difference?

Researchers have explored the impact of various diets on weight gain in patients taking pregabalin. A study published in the Journal of Clinical Psychopharmacology found that patients on a low-calorie diet experienced significantly less weight gain than those on a standard diet [3]. On the other hand, another study suggested that a high-fat diet may be associated with greater weight gain in pregabalin-treated patients [4].

High-Protein Diets: A Potential Solution?

A growing body of evidence suggests that high-protein diets may be beneficial for individuals taking pregabalin, as they tend to promote greater satiety and weight loss [5]. In contrast, high-carbohydrate diets may be associated with increased weight gain, possibly due to the body's tendency to store excess glucose as fat [6].

Other Factors to Consider

It is essential to note that individual results may vary significantly, and other factors such as sleep quality, stress levels, and overall physical activity can also influence weight gain while taking pregabalin.

Who Makes Lyrica?

Lyrica (pregabalin) is manufactured by a number of pharmaceutical companies, including Pfizer and Teva Pharmaceuticals [7].

When Does Exclusivity Expire?

The exclusivity period for Lyrica has already expired in many countries [8].

Regulatory Status

Lyrica is approved for use in the US, Europe, and other countries for the treatment of various conditions, including epilepsy, anxiety disorders, and fibromyalgia [9].

Sources:

[1] https://www.ncbi.nlm.nih.gov/pubmed/21403292
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751134/
[3] https://www.ncbi.nlm.nih.gov/pubmed/21665443
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751134/
[5] https://www.ncbi.nlm.nih.gov/pubmed/27564915
[6] https://www.ncbi.nlm.nih.gov/pubmed/26444553
[7] https://www.drugpatentwatch.com/drug/lyrica
[8] https://www.drugpatentwatch.com/description/LYRICA
[9] https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021323s030lbl.pdf